The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...

With EV sales growth slowing and threats by President Trump to impose tariffs, pause infrastructure buildout and end federal ...

Mitsubishi Motors is facing a tough financial year, with the company slashing its net profit forecast by a staggering 76%.

Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ("Tanabe Pharma", "MTPC" or "the Company") ...

TOKYO -- Japan's Mitsubishi Chemical Group announced on Friday the agreed sale of its pharmaceutical subsidiary, Mitsubishi Tanabe Pharma, to U.S. investment fund Bain Capital for approximately 510 ...

Mitsubishi Electric Corporation (TOKYO: 6503) announced today that the international nonprofit CDP has once again given ...

Mitsubishi Corp. took a 52.2 billion yen ($342.4 million) impairment charge on its domestic offshore wind projects in the ...

Korean Air anticipates uncertainties in the business environment this year due to shifts in the global political landscape, ...

Avolon has settled a lawsuit against a number of insurers over jets that were prevented from leaving Russia when Western ...

Yamaha Corporation (hereafter, Yamaha) confirms its partnership with Mitsubishi Motors North America, Inc. (MMNA) as part of ...

At 60 years old, Jean-Marc Gilson wasn’t sure if he wanted to be a CEO — again. But Westlake was calling his name.